RALEIGH, N.C., Jan. 9 /PRNewswire/ -- CLOSURE Medical Corporation
(Nasdaq: CLSR), a medical tissue adhesive products company, today announced
that on January 11, 2001 at 4:30 p.m. EST, it intends to discuss its recently
announced agreement with Colgate Oral Pharmaceuticals, Inc. for the marketing
and distribution of its SOOTHE-N-SEAL(TM) product. In addition, the Company
will also be prepared to discuss an overview of its financial performance
outlook for 2001 and the effects of adopting Staff Accounting Bulletin No.
101.
CLOSURE will host a conference call that will be broadcast simultaneously
live over the internet. Individuals wishing to participate on the webcast, to
be held at 4:30 p.m. EST on Thursday January 11, 2001, can access the event at
http://www.vcall.com . Please allow extra time prior to the call to visit
the site to download the streaming media software required to listen to the
Internet broadcast. The online archive of the broadcast will be available
within 3 hours of the live call and will be available for replay for 30 days.
CLOSURE Medical Corporation, headquartered in Raleigh, North Carolina,
develops, manufactures and commercializes medical tissue adhesive products
based on its proprietary cyanoacrylate technology. CLOSURE's nonabsorbable
tissue adhesive products may be used to replace sutures and staples for
certain topical wound closure applications, while its internal tissue adhesive
products can potentially be used for internal wound closure and management.
Currently marketed nonabsorbable tissue adhesive products include
DERMABOND(R)* Topical Skin Adhesive, which is used to replace sutures and
staples for closure of certain lacerations and incisions; OCTYLDENT(R)*
adhesive, which is used as an adjunct in the treatment of adult periodontal
disease; and the NEXABAND(R)* line of topical adhesives, which are used in
veterinary wound closure and management.
* DERMABOND(R) adhesive is a trademark of Ethicon, Inc.; SOOTHE-N-SEAL(TM)
canker sore relief and LIQUIDERM(TM) adhesive are trademarks of CLOSURE
Medical Corporation. OCTYLDENT(R) adhesive and NEXABAND(R) adhesives are
federally registered trademarks of CLOSURE Medical Corporation.
To receive CLOSURE's latest news release and other corporate documents via
fax, at no cost, call 1-800-PRO-INFO, use the Company's symbol CLSR. Or visit
the Financial Relations Board's website at http://www.frbinc.com .
This release contains certain forward-looking statements which involve
known and unknown risks, delays, uncertainties or other factors not under the
Company's control which may cause actual results, performance or achievements
of the Company to be materially different from the results, performance, or
other expectations implied by these forward-looking statements. These factors
include, but are not limited to the early stage of commercialization of the
Company products; the progress of its research and development programs for
future products; the need for regulatory approval and effects of governmental
regulation; technological uncertainties; the satisfactory conclusion of
negotiations with, and dependence on marketing partners, and dependence on
patents and trade secrets, as well as those detailed in the Company's Annual
Report on Form 10-K for the year ended December 31, 1999 filed with the
Securities and Exchange Commission.
SOURCE CLOSURE Medical Corporation
 back to top
Related links:
http://www.frbinc.com
CONTACT:
Robert V. Toni, President & CEO, or Benny
Ward, CFO, both of CLOSURE Medical Corporation, 919-876-7800;
General, Stuart Z. Levine, Ph.D., Analysts, Cecelia Heer, or
Media, Deanne Eagle, all of The Financial Relations Board,
212-661-8030
|
